A new wave of innovation in neurological healthcare is taking shape as Australian not-for-profit MSWA, in partnership with global accelerator and venture studio Founders Factory, unveils the first cohort of startups joining its MS & Neurological Care Accelerator.
The initiative is designed to speed up the development of technologies that can improve daily life for people living with complex neurological conditions, including multiple sclerosis (MS), stroke, Parkinson’s disease, Huntington’s disease, motor neurone disease (MND), and acquired brain injury.
Real-World Testing Through Clinical Collaboration
Unlike traditional startup programs, the accelerator offers participating ventures direct access to MSWA’s extensive clinical network and a community of thousands of individuals affected by neurological conditions across Western Australia, South Australia, and the Northern Territory.
This access will allow startups to test and refine their innovations in real-world environments, helping ensure that solutions are not only technologically advanced but also practical and responsive to patient needs.
A Mix of Emerging Technologies Driving New Care Models
The selected startups are working across a wide range of cutting-edge technologies, including artificial intelligence, brain-computer interfaces, robotics, wearable devices, and advanced health monitoring tools.
These innovations are aimed at addressing both physical and cognitive challenges faced by patients, with a focus on improving independence, mobility, communication, and overall quality of life.
Meet the Five Startups in the First Cohort
The inaugural group features five early-stage companies from different parts of the world, each developing distinct approaches to neurological care.
London-based upLYFT is building a “Movement Intelligence” platform that turns everyday textiles into an invisible system for tracking health and performance, offering new ways to understand movement patterns.
From San Francisco, Neurosonic is developing a stroke prevention solution that detects and monitors carotid artery blockages using blood flow sound analysis supported by a proprietary database.
Melbourne’s Fluent is working on a subscalp brain-computer interface designed to decode speech, potentially offering new communication pathways for individuals affected by severe neurological impairments.
Clarity Technologies, based between San Francisco and Paris, is creating a device that uses sensory stimulation therapy to address neurodegenerative symptoms, including fatigue experienced by people living with MS.
Boston-based ReVimo is developing a portable robotic self-transfer device that helps individuals with mobility challenges move out of bed and perform daily self-care tasks more safely and independently.
Global Accelerator to Operate from Western Australia
The MS & Neurological Care Tech Accelerator will be based in Perth, Western Australia, positioning the region as a growing hub for neurotechnology innovation and healthcare advancement.
Through this initiative, MSWA continues its broader mission of supporting individuals living with neurological conditions and providing essential services to affected communities across multiple Australian regions.
By combining clinical expertise with startup innovation, the program aims to accelerate the delivery of practical, life-changing technologies for people living with neurological disorders worldwide.
